Passionate about IP! Since June 2003 the IPKat has covered copyright, patent, trade mark, designs, info-tech and confidentiality issues from a mainly UK and European perspective. Read, post comments and participate!

The team is Eleonora Rosati, Annsley Merelle Ward and Merpel. E-mail the Kats here!

The team is joined by GuestKats Söğüt Atilla, Oliver Fairhurst, Claire Gregg, Georgia Jenkins and Marcel Pemsel.

SpecialKats: Verónica Rodríguez Arguijo (TechieKat), Rose Hughes (PatKat) and Jocelyn Bosse (Book Review Editor).

InternKats: Wissam Bentazar, Simone Lorenzi and Kliment Markov.
Results for AstraZeneca
UK court reaffirms its stringent plausibility standard in AstraZeneca despite G 2/21 UK court reaffirms its stringent plausibility standard in AstraZeneca despite G 2/21 Reviewed by Annsley Merelle Ward on Friday, May 09, 2025 Rating: 5

Around the IP Blogs!

Another busy week in the IP blog world! If you didn’t have enough time to even take a Katnap and require an update on recent IP news, here’...
- Wednesday, January 23, 2019
Around the IP Blogs! Around the IP Blogs! Reviewed by Tosshan Ramgolam on Wednesday, January 23, 2019 Rating: 5
Never Too Late: If you missed the IPKat Last Week! Never Too Late: If you missed the IPKat Last Week! Reviewed by Tian Lu on Wednesday, July 05, 2017 Rating: 5
When the biter gets bit: Cross-undertakings in damages When the biter gets bit: Cross-undertakings in damages Reviewed by David Brophy on Friday, May 22, 2015 Rating: 5
The skilled person - more knowledgeable than ever before The skilled person - more knowledgeable than ever before Reviewed by David Brophy on Thursday, September 04, 2014 Rating: 5
Feeling fine? Europe enriched by AstraZeneca's millions Feeling fine? Europe enriched by AstraZeneca's millions Reviewed by Jeremy on Thursday, December 06, 2012 Rating: 5
AstraZeneca fine looks fine, says AG Mazák AstraZeneca fine looks fine, says AG Mazák Reviewed by Jeremy on Tuesday, May 15, 2012 Rating: 5
Subscribe to: Posts ( Atom )
Powered by Blogger.